Skip to main content

Roche Virtual Event – Update following ASH 2022

Roche has hosted a virtual event on Wednesday, 14 December 2022.

agenda
Agenda
WelcomeBruno Eschli, Head of Investor Relations
Hematology franchise overviewPeter Ahnesorg, Franchise Head Hematology
Review of key clinical data presented at ASHCharles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development
Spark Therapeutics, Inc. (SPK-8011) clinical data updateGallia G. Levy, MD, PhD, Chief Medical and Product Strategy Officer

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.